-
Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)YX Jiang, MA Turk, JE Pope et al. -
中国肺高血压诊断和治疗指南2018中华医学会心血管病学分会肺血管病学组, 中华心血管病杂志编辑委员会。 -
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trialBermejo J, Yotti R, SIOVAC investigators et al.
-
Bridging the Gap Between Epigenetic and Genetic in PAHFrançois Potus, PhD; Stephen L. Archer, MD, FACC
-
rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular RemodelingRathinasabapathy A, Bryant AJ, Suzuki T et al.
-
Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension)Chen SL, Zhang FF, Xu J et al.
-
Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart diseaseZhang H, Zhang J, Chen SL et al.
-
Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized MonocrotalineZhou L, Zhang J, Chen SL et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
